Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |